Want to Add a New Partner to Your Practice? at AshTip Solution.

BORDEAUX, France — Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy of AEF0117 in patients with cannabis use disorder have created quite a stir. The study was published in Nature Medicine. Not only did AEF0117 weaken the effects of cannabis, but it also decreased a person's desire to use it, all without causing withdrawal symptoms. These findings have generated a significant buzz in the scientific and medical community. 2023-06-23

SAN DIEGO ― Prescribing optimal medical therapy for people with both type 2 diabetes and cardiovascular disease can and should improve, speakers urged at the recent American Diabetes Association (ADA) 83rd Scientific Sessions. 2023-07-03

I remember what it was like to be a medical student at a well-known cancer hospital where patients were dying of cancer. In life's final stages, it was not uncommon for physicians to increase the dose of morphine; it alleviated pain, eased labored breathing, and yes, probably hastened the inevitable for patients who were in their final hours. In these scenarios, no one considered this euthanasia, and no one questioned whether it was the right thing to do. 2023-07-07

In a move that raises the stakes in doctors' ongoing scope-creep battle against nonphysician providers, the American Medical Association's (AMA) legislative body voted recently to change its policy on the supervision of advanced practice registered nurses (APRNs). AMA's House of Delegates called for state medical boards to regulate APRNs in addition to nursing boards. 2023-07-06